$3.94 Bn Hematology Analyzer Markets - Global Opportunity Analysis and Industry Forecast, 2021-2030. - ResearchAndMarkets.com
The "Hematology Analyzer Market by Product & Service, Type and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030."
The "Hematology Analyzer Market by Product & Service, Type and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030." report has been added to ResearchAndMarkets.com's offering.
The global hematology analyzer market was valued at $1,962.40 million in 2020 and is projected to reach $3,941.10 million by 2030 registering a CAGR of 7.30% from 2021 to 2030.
Hematology is a branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to the blood. Hematology analyzers are used in the diagnosis and treatment of a wide range of diseases related to red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting.
Hematology analyzers are used to conduct a complete blood count (CBC), which is usually the first test requested by physicians to determine a patients general health status. A complete blood count includes red blood cell (RBC), white blood cell (WBC), hemoglobin, and platelet counts, as well as hematocrit levels.
Other analyses include RBC distribution width, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentrations, WBC differential count in percentage and absolute value, platelet distribution width, platelet mean volume, large platelet cell ratio, platelet criteria.
The main driving factors that drive growth of the hematology analyzer market include, increase in prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood. In addition, technological advancements in hematology analyzers, and growth in demand for automated hematology analyzer coupled with rising preference towards high sensitivity hematology analyzer further boost the growth of the hematology analyzer market.
However, high cost of hematology analyzers owing to advanced features and automation may hamper the growth of the market. Furthermore, stringent regulatory policies for hematology analyzers are also expected to limit growth of the market. In contrast, growth opportunities in emerging economics expected to offer lucrative growth opportunities for players in the hematology analyzer market.
MARKET DYNAMICS
Drivers
- Increase in prevalence of blood disorders
- Technological advancements in hematology analyzers
- Growth in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer
Restraints
- High cost of hematology analyzers
- Stringent regulatory policies for hematology analyzers
Opportunities
- Growth opportunities in emerging economics
KEY PLAYERS PROFILED IN THE REPORT
- Abbott Laboratories
- Danaher Corporation (Beckman Coulter Inc.)
- Bio-Rad Laboratories
- Boule Diagnostics AB
- F Hoffmann-La Roche Ltd
- Hobira Ltd
- Nihon Kohden Corporation,
- Siemens Healthineers
- Stratec SE (Diatron MI Plc.)
- Sysmex Corporation.
KEY MARKET SEGMENTS
By Product & Service
- Instruments
- Reagents & Consumables
- Services
By Type
- Fully Automated Hematology Analyzers
- Semi-automated Hematology Analyzers
By End User
- Hospitals
- Clinical Laboratories
- Research Institutes
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
For more information about this report visit https://www.researchandmarkets.com/r/s2wz22
View source version on businesswire.com: https://www.businesswire.com/news/home/20211123005772/en/